Dual-Targeting CAR-NK Cells for Recurrent/Progressive Glioblastoma and High-Grade Glioma

Clinical trial NCT07551336 · RECRUITING

Trial details

NCT number: NCT07551336
Sponsor: Beijing Biotech
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Malignant Glioma High-Grade Gliomas Glioblastoma Recurrent High-Grade Gliomas Recurrent Glioblastoma

Start date: 2026-03-02
Primary completion: 2027-04-14
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.